Cover Image
市場調查報告書

北美的感染疾病診斷藥市場未來展望

North America Infectious Diagnostics Market Outlook to 2021

出版商 GlobalData 商品編碼 347959
出版日期 內容資訊 英文 215 Pages
訂單完成後即時交付
價格
Back to Top
北美的感染疾病診斷藥市場未來展望 North America Infectious Diagnostics Market Outlook to 2021
出版日期: 2015年10月01日 內容資訊: 英文 215 Pages
簡介

本報告提供北美各國 (美國·加拿大·墨西哥) 的各種感染疾病診斷藥市場相關分析,提供您整體市場規模 (以金額為準) 的實際成果值·預測值的動向,及各企業·各銷售管道的市場佔有率結構,各國市場詳細趨勢,主要企業簡介,主要的開發中產品現況 (開發平台實驗的進展階段等),近來市場主要動向等相關調查。

第1章 目錄

第2章 簡介

  • 本報告的問題的認知
  • 感染疾病診斷藥市場明細
  • 本報告分析範圍

第3章 北美各國的感染疾病診斷藥市場

  • 市場收益額趨勢預測 (總計15年份)
  • 市場收益額比較:各類別 (總計15年份)
  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
  • 各企業的市場佔有率 (以收益為準)

第4章 加拿大的感染疾病診斷藥市場

  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
    • 感染疾病快速診斷·POC (照護現場) 產品的市場:實際成果值 (過去8年份)
    • 感染疾病快速診斷·POC (照護現場) 產品的市場:預測值 (今後8年份)
  • 各流通管道的市場佔有率 (以收益為準)
  • 各企業的市場佔有率 (以收益為準)

第5章 墨西哥的感染疾病診斷藥市場

第6章 美國的感染疾病診斷藥市場

第7章 主要企業概要

  • Hologic, Inc.
    • 企業概要
  • Abbott Laboratories
  • Qiagen N.V.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Siemens Healthcare
  • Danaher Corporation
  • Alere Inc.
  • bioMerieux S.A.
  • DiaSorin S.p.A
  • Cepheid

第8章 感染疾病診斷藥市場開發中產品

第9章 資本交易環境

  • patonashippu (產業聯盟) (1件)

第10章 近來的市場趨勢

  • 企業宣傳 (企業通訊) (全30件)
  • 公佈財報 (全71件)
  • 政府·公共機關相關趨勢 (1件)
  • 法規·規定相關的動向 (全4件)
  • 其他重要的動向 (全10件)
  • 產品新聞 (全4件)
  • 策略·產業計畫 (全8件)

第11章 附錄

圖表一覽

目錄
Product Code: GDMECR0326DB

GlobalData's new report, "North America Infectious Diagnostics Market Outlook to 2021", provides key market data on the North America Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Infectious Diagnostics market.
  • Global corporate-level profiles of key companies operating within the North America Infectious Diagnostics market.
  • Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Infectious Diagnostics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Infectious Diagnostics Market, North America

  • 3.1. Infectious Diagnostics Market, North America, Revenue ($m), 2007-2021
  • 3.2. Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Infectious Diagnostics Market, North America, Revenue ($m), 2007-2014
  • 3.4. Infectious Diagnostics Market, North America, Revenue ($m), 2014-2021
  • 3.5. Infectious Diagnostics Market, North America, Company Share by Revenue ($m), 2014

4. Infectious Diagnostics Market, Canada

  • 4.1. Infectious Diagnostics Market, Canada, Revenue ($m), 2007-2014
  • 4.2. Infectious Diagnostics Market, Canada, Revenue ($m), 2014-2021
    • 4.2.1. Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), by Segment, 2014-2021
  • 4.3. Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 4.4. Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), 2014

5. Infectious Diagnostics Market, Mexico

  • 5.1. Infectious Diagnostics Market, Mexico, Revenue ($m), 2007-2014
  • 5.2. Infectious Diagnostics Market, Mexico, Revenue ($m), 2014-2021
    • 5.2.1. Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), by Segment, 2014-2021
  • 5.3. Infectious Diagnostics Market, Mexico, Distribution Share by Revenue ($m), 2013-2014
  • 5.4. Infectious Diagnostics Market, Mexico, Company Share by Revenue ($m), 2014

6. Infectious Diagnostics Market, United States

  • 6.1. Infectious Diagnostics Market, United States, Revenue ($m), 2007-2014
  • 6.2. Infectious Diagnostics Market, United States, Revenue ($m), 2014-2021
    • 6.2.1. Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), by Segment, 2014-2021
  • 6.3. Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 6.4. Infectious Diagnostics Market, United States, Company Share by Revenue ($m), 2014

7. Overview of Key Companies in North America Infectious Diagnostics Market

  • 7.1. Hologic, Inc.
    • 7.1.1. Company Overview
  • 7.2. Abbott Laboratories
    • 7.2.1. Company Overview
  • 7.3. Qiagen N.V.
    • 7.3.1. Company Overview
  • 7.4. F. Hoffmann-La Roche Ltd.
    • 7.4.1. Company Overview
  • 7.5. Becton, Dickinson and Company
    • 7.5.1. Company Overview
  • 7.6. Siemens Healthcare
    • 7.6.1. Company Overview
  • 7.7. Danaher Corporation
    • 7.7.1. Company Overview
  • 7.8. Alere Inc.
    • 7.8.1. Company Overview
  • 7.9. bioMerieux S.A.
    • 7.9.1. Company Overview
  • 7.10. DiaSorin S.p.A
    • 7.10.1. Company Overview
  • 7.11. Cepheid
    • 7.11.1. Company Overview

8. Infectious Diagnostics Market Pipeline Products

9. Financial Deals Landscape

  • 9.1. Partnerships
    • 9.1.1. Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics

10. Recent Developments

  • 10.1. Corporate Communications
    • 10.1.1. Aug 19, 2015: Quidel Announces Changes to Board of Directors
    • 10.1.2. Aug 17, 2015: MedMira Board Reinforces Biotech Bench Strength with New Appointment
    • 10.1.3. Jul 08, 2015: Aethlon Medical Announces Nasdaq Capital Market Listing Approval
    • 10.1.4. Jun 25, 2015: Cardiac Dimensions Announces Initial Enrollments in REDUCE FMR Clinical Trial
    • 10.1.5. Jun 25, 2015: CombiMatrix Expands Sales Team to Accelerate Entry Into New Markets
    • 10.1.6. Jun 22, 2015: InVivo Therapeutics Receives Notice of Allowance on Patent Covering Broader Compositions for Neuro-Spinal Scaffold and Neuro-Spinal Scaffold Plus Stem Cells
    • 10.1.7. Jun 18, 2015: Dutch hospital acquires 1,000th Agility, Elekta's radiotherapy beam-shaping technology for treating cancer
    • 10.1.8. Jun 17, 2015: Newly FDA-Approved Device for Stroke Prevention Available at Mercy
    • 10.1.9. Jun 09, 2015: Aethlon Medical Announces Resignation of Inside Director to Comply with NASDAQ Corporate Governance Requirements
    • 10.1.10. May 06, 2015: ERBA Diagnostics Appoints Ernesina Scala as Chief Financial Officer and Chandra Krishnan as Senior Vice President Global Sales, Marketing and Business Development
    • 10.1.11. Apr 07, 2015: Cepheid Welcomes Executive Vice President And Chief Financial Officer
    • 10.1.12. Mar 18, 2015: Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer
    • 10.1.13. Mar 16, 2015: CombiMatrix Appoints Lale White to Board of Directors
    • 10.1.14. Mar 05, 2015: New Study in Journal of Tissue Viability Recognizes SEM Scanner's Clinical Utility in Detection of Pressure Ulcers
    • 10.1.15. Mar 03, 2015: SQI Diagnostics Appoints Chief Financial Officer
    • 10.1.16. Jan 20, 2015: CombiMatrix Names Karen Warner, RN, Vice President of Reimbursement
    • 10.1.17. Jan 08, 2015: Quest Diagnostics Names New Health Plan Leader
    • 10.1.18. Jan 08, 2015: Chembio Appoints Paul Lambotte as Vice President, Product Development
    • 10.1.19. Jan 06, 2015: Former President of BIO Joins Trovagene's Board of Directors
    • 10.1.20. Nov 19, 2014: CombiMatrix Promotes Karine Hovanes, Ph.D., To Vice President Of Scientific Advancement And Laboratory Director, And Trilochan Sahoo, M.D., To Vice President Of Clinical Affairs And Director Of Cytogenetics
    • 10.1.21. Nov 18, 2014: Dr. Kenneth J. Widder Joins Quidel's Board of Directors
    • 10.1.22. Nov 10, 2014: C3 Jian Adds Two Top Oral Healthcare Professionals To Its Board Of Directors
    • 10.1.23. Nov 04, 2014: MedMira Names Robyn Cook As Chief Corporate Officer
    • 10.1.24. Oct 29, 2014: Lucigen Announces Ralph Kauten as CEO
    • 10.1.25. Oct 22, 2014: Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
    • 10.1.26. Oct 15, 2014: Luminex Announces Retirement of Patrick Balthrop, President and CEO
    • 10.1.27. Oct 02, 2014: 3-V Biosciences To Present Clinical And Preclinical Data For FASN Inhibitors At EORTC-NCI-AACR 2014
    • 10.1.28. Oct 01, 2014: Quest Diagnostics Names Mayo Clinic Executive Franklin R. Cockerill, M.D., Vice President and Chief Laboratory Officer
    • 10.1.29. Sep 29, 2014: SQI Diagnostics Announces New Chairman of Board of Directors
    • 10.1.30. Sep 24, 2014: Spectral announces board changes
  • 10.2. Financial Announcements
    • 10.2.1. Aug 25, 2015: High Throughput Single-Cell mRNA Sequencing Preparation Comes to the Fluidigm C1 System
    • 10.2.2. Aug 25, 2015: SPR Therapeutics Awarded $1.6M NIH Grant to Study Pain Management Following Knee Replacement Surgery Using the Sprint PNS System
    • 10.2.3. Aug 25, 2015: Xtant Medical Announces FDA Approval of OsteoSelect PLUS
    • 10.2.4. Aug 25, 2015: Multi-center ALS Study Using the NeuRx Diaphragm Pacing System Shows Safety and Survival Post-Implant of 20.9 Months
    • 10.2.5. Aug 18, 2015: SQI Diagnostics Reports Third Quarter Financial Results
    • 10.2.6. Aug 14, 2015: Spectral Announces Second Quarter 2015 Results
    • 10.2.7. Aug 13, 2015: Aethlon Medical Announces Fiscal 2016 First Quarter Results
    • 10.2.8. Aug 10, 2015: Trovagene Announces Second Quarter 2015 Financial Results
    • 10.2.9. Aug 06, 2015: Chembio Diagnostics Reports Second Quarter Financial Results
    • 10.2.10. Aug 05, 2015: ERBA Diagnostics Reports 2nd Quarter 2015 Financial Results
    • 10.2.11. Aug 04, 2015: CombiMatrix Reports Second Quarter 2015 Financial and Operating Results
    • 10.2.12. Aug 03, 2015: Luminex Reports Record 2nd Quarter 2015 Results
    • 10.2.13. Jul 28, 2015: Neogen's new NeoSal designed to simplify oral fluid collection
    • 10.2.14. Jul 27, 2015: Neogen launches NeoSeek Salmonella serotyping service
    • 10.2.15. Jul 23, 2015: Quest Diagnostics Reports Second Quarter 2015 Financial Results
    • 10.2.16. Jul 23, 2015: Cepheid Reports 2015 Second Quarter Results
    • 10.2.17. Jul 22, 2015: Quidel Reports Second Quarter 2015 Financial Results
    • 10.2.18. Jun 26, 2015: ERBA Diagnostics Reports 1st Quarter 2015 Financial Results
    • 10.2.19. Jun 17, 2015: Derma Sciences Announces Medicare Coverage Reinstated For MEDIHONEY Products with Reimbursable Codes by Centers for Medicare & Medicaid Services
    • 10.2.20. Jun 03, 2015: Sirona Biochem CEO Update: Significant Interest from Top Cosmetic and Pharmaceutical Companies for Lead Compounds
    • 10.2.21. May 21, 2015: SQI Diagnostics Reports Second Quarter Financial Results
    • 10.2.22. May 18, 2015: ERBA Diagnostics Reports 2014 Financial Results; Announces Delay in Filing Quarterly Report on Form 10-Q
    • 10.2.23. May 13, 2015: Spectral Announces First Quarter 2015 Results
    • 10.2.24. May 09, 2015: Shanghai MicroPort Orthopedics Hosts First SuperPath Online Symposium
    • 10.2.25. May 07, 2015: Chembio Diagnostics Reports First Quarter 2015 Financial Results
    • 10.2.26. May 07, 2015: CombiMatrix Reports First Quarter 2015 Financial and Operating Results
    • 10.2.27. May 06, 2015: ARIAD Announces Commercial Distribution Agreement for Iclusig (ponatinib) in Turkey
    • 10.2.28. May 05, 2015: Trovagene Announces First Quarter 2015 Financial Results
    • 10.2.29. May 04, 2015: Luminex Reports First Quarter 2015 Results
    • 10.2.30. Apr 23, 2015: Quidel Reports First Quarter 2015 Financial Results
    • 10.2.31. Apr 23, 2015: Quest Diagnostics Reports First Quarter 2015 Financial Results
    • 10.2.32. Apr 23, 2015: Cepheid Reports 2015 First Quarter Results
    • 10.2.33. Mar 25, 2015: Spectral Announces Fourth Quarter and Fiscal 2014 Results
    • 10.2.34. Mar 20, 2015: MedMira Reports Second Quarter Financial Results
    • 10.2.35. Mar 19, 2015: AHN Offers Innovative Minimally-Invasive Surgical Procedure for Patients with Common, Yet Difficult to Diagnose, Form of Recurring Back Pain
    • 10.2.36. Mar 18, 2015: Blue Belt Technologies Announces First Navio Case Performed in Australia and First Navio-assisted GRU Unicompartmental Knee Replacement
    • 10.2.37. Mar 17, 2015: LG Health receives first upgrade to its CyberKnife M6 System
    • 10.2.38. Mar 17, 2015: Mediware to Unveil CareTend Software at NHIA Conference
    • 10.2.39. Mar 13, 2015: Patients With Prostate Cancer Face an Uncertainty in Their Future Treatment After NHS England Decision
    • 10.2.40. Mar 12, 2015: Trovagene Reports Fourth Quarter and Full Year 2014 Financial Results
    • 10.2.41. Mar 05, 2015: Mazor Robotics Renaissance Guidance System Helping Patients with OCD
    • 10.2.42. Mar 05, 2015: Chembio Diagnostics Reports 2014 Financial Results
    • 10.2.43. Mar 04, 2015: Exact Sciences Announces Aetna Medicare Advantage to Cover Cologuard
    • 10.2.44. Mar 04, 2015: Myriad Publishes myPath Melanoma Pivotal Validation Study in the Journal of Cutaneous Pathology
    • 10.2.45. Mar 04, 2015: PositiveID Corporation Files U.S. Patent for Its Firefly Dx Real-Time PCR System
    • 10.2.46. Mar 03, 2015: Oxford Immunotec Reports Fourth Quarter and Full Year 2014 Financial Results
    • 10.2.47. Feb 26, 2015: SQI Diagnostics Reports First Quarter Financial Results
    • 10.2.48. Feb 25, 2015: CombiMatrix Reports Fourth Quarter and Full Year 2014 Financial and Operating Results
    • 10.2.49. Feb 20, 2015: Neuronetrix receives FDA clearance to market COGNISION for use in the clinic
    • 10.2.50. Feb 12, 2015: FDA Classifies Previous Covidien Field Action for Its Trellis-6 Peripheral Infusion Systems As a Class 1 Recall
    • 10.2.51. Feb 11, 2015: Quidel Reports Fourth Quarter and Full Year 2014 Financial Results
    • 10.2.52. Feb 10, 2015: Aethlon Medical Reports Q3 Fiscal 2015 Results
    • 10.2.53. Feb 02, 2015: Luminex Reports Fourth Quarter And Full Year 2014 Results
    • 10.2.54. Jan 29, 2015: Cepheid Reports Fourth Quarter And Full Year 2014 Results
    • 10.2.55. Jan 29, 2015: Quest Diagnostics Reports Fourth Quarter and Full Year 2014 Financial Results; Provides Guidance For Full Year 2015; Increases Dividend 15%
    • 10.2.56. Dec 31, 2014: MicroPort Completes First Implantation of Reewarm18
    • 10.2.57. Dec 24, 2014: MedMira Reports First Quarter Results
    • 10.2.58. Dec 17, 2014: SQI Diagnostics Reports Fourth Quarter and Fiscal 2014 Results
    • 10.2.59. Nov 28, 2014: MedMira Reports 2014 Fourth Quarter And Year End Financial Results
    • 10.2.60. Nov 24, 2014: Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA
    • 10.2.61. Nov 13, 2014: Spectral Announces Third Quarter 2014 Results
    • 10.2.62. Nov 10, 2014: ERBA Diagnostics Reports 3rd Quarter Financial Results
    • 10.2.63. Nov 10, 2014: Aethlon Medical Reports Q2 Fiscal 2015 Results
    • 10.2.64. Nov 06, 2014: Trovagene Announces Third Quarter 2014 Financial Results
    • 10.2.65. Nov 06, 2014: Chembio Diagnostics Reports Third Quarter 2014 Financial Results
    • 10.2.66. Nov 04, 2014: CombiMatrix Reports Third Quarter 2014 Financial and Operating Results
    • 10.2.67. Oct 27, 2014: Luminex Reports Third Quarter 2014 Results
    • 10.2.68. Oct 23, 2014: Quest Diagnostics Reports Third Quarter 2014 Financial Results
    • 10.2.69. Oct 21, 2014: Quidel Reports Third Quarter 2014 Financial Results
    • 10.2.70. Oct 16, 2014: Cepheid Reports 2014 Third Quarter Results
    • 10.2.71. Oct 07, 2014: CombiMatrix Reports Preliminary Growth in Prenatal Microarray Testing Volumes of 71% and 64% for the Third Quarter and Year-to-Date, Respectively
  • 10.3. Government and Public Interest
    • 10.3.1. Jan 26, 2015: Trovagene's Chief Scientific Officer to Present Precision Cancer Monitoring Platform Overview at the Personalized Medicine World Conference
  • 10.4. Legal And Regulatory
    • 10.4.1. Jul 06, 2015: Enzo Biochem Reaches $7.1 Million Patent Infringement Settlement with Luminex
    • 10.4.2. Apr 28, 2015: CombiMatrix Executes Final Settlement Ending Litigation
    • 10.4.3. Mar 12, 2015: Superior Court Issues Final Statement of Decision and Enters Judgment in Favor of CombiMatrix
    • 10.4.4. Jan 06, 2015: Superior Court Issues Tentative Ruling and Proposed Statement of Decision in Favor of CombiMatrix
  • 10.5. Other Significant Developments
    • 10.5.1. May 05, 2015: Lucigen Expands Technological Reach with Exclusive Sigma-Aldrich Distribution Agreement
    • 10.5.2. Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche
    • 10.5.3. Mar 19, 2015: CombiMatrix Announces Payor Contract With InterWest Health
    • 10.5.4. Feb 10, 2015: Rheonix Receives $1.5 Million SBIR Phase II Grant from the National Institute of Dental & Craniofacial Research of the National Institutes of Health
    • 10.5.5. Jan 28, 2015: Two of MedMira's Multiplo Tests Procured for UNAIDS Program in Central Asia
    • 10.5.6. Jan 26, 2015: Erba Diagnostics Expands U.S. Distribution Network
    • 10.5.7. Dec 16, 2014: Spectral Announces Effective Date of Name Change
    • 10.5.8. Dec 15, 2014: SQI Diagnostics Wins Additional Business from UK-based Customer
    • 10.5.9. Dec 04, 2014: Quest Diagnostics Declares Quarterly Cash Dividend
    • 10.5.10. Nov 05, 2014: Bearing Analytics Changes Name To DATTUS, Opens Office In India
  • 10.6. Product News
    • 10.6.1. Jun 25, 2015: Study Published In May Issue Of Journal Of Dermatologic Surgery Demonstrates Significant Improvement In Face And Neck Treatment Results From New Profound Non-Surgical Procedure
    • 10.6.2. Nov 19, 2014: Seegene Receives US Patent for TOCE Technology
    • 10.6.3. Oct 21, 2014: GENETWORx Launches a New Personal Health Panel for Advanced Diagnosis of Genital and Gastrointestinal Pathogens
    • 10.6.4. Sep 29, 2014: Trovagene Expands Clinical Program with New Study Evaluating its Precision Cancer Monitoring Platform in Lung Cancer
  • 10.7. Strategy And Business Planning
    • 10.7.1. Aug 12, 2015: CINDE Announces Pharmaceutical Invested $5.5 Million for New Headquarters
    • 10.7.2. Jul 20, 2015: MedMira Opens US Subsidiary in Atlanta, GA
    • 10.7.3. May 04, 2015: QIAGEN Partners With World's Largest Sequencing Provider
    • 10.7.4. Jan 12, 2015: Trovagene Collaborates with UC San Diego Moores Cancer Center to Demonstrate Clinical Utility of Detecting and Monitoring EGFR Mutations in Lung Cancer Patients
    • 10.7.5. Oct 28, 2014: NovaBiotics Establishes a US Presence
    • 10.7.6. Oct 22, 2014: ERBA Diagnostics Enters Brazilian Market; Offers In Vitro Diagnostics to Hospitals, Testing Labs and Physicians Clinics
    • 10.7.7. Oct 02, 2014: Quest Diagnostics Unveils New State-of-the-Art Clinical Laboratory In Marlborough, Massachusetts
    • 10.7.8. Sep 26, 2014: Aethlon Medical and Exosome Sciences Announce Clinical Collaboration with Boston University CTE Center To Advance Diagnostic Candidate to Detect CTE in Former NFL Players

11. Appendix

  • 11.1. Research Methodology
    • 11.1.1. Coverage
    • 11.1.2. Secondary Research
    • 11.1.3. Primary Research
    • 11.1.4. Company Share Analysis
    • 11.1.5. Distribution Share Analysis
  • 11.2. GlobalData Consulting
  • 11.3. Contact Us
  • 11.4. Disclaimer

List of Tables

  • Table 1: Infectious Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Infectious Diagnostics Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Infectious Diagnostics Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Infectious Diagnostics Market, North America, Company Share by Revenue ($m), USD Constant, 2014
  • Table 6: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 7: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 9: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 10: Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 11: Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 12: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 14: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 15: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Infectious Diagnostics Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 17: Infectious Diagnostics Market, Mexico, Company Share by Revenue ($m), USD Constant, 2014
  • Table 18: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 19: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 20: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 21: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 22: Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 23: Infectious Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 24: Infectious Diagnostics Market Pipeline Products
  • Table 25: Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics

List of Figures

  • Figure 1: Infectious Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Infectious Diagnostics Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Infectious Diagnostics Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Infectious Diagnostics Market, North America, Company Share (%) 2014
  • Figure 6: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 7: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 9: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 10: Infectious Diagnostics Market, Canada, Company Share (%) 2014
  • Figure 11: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 13: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 14: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 15: Infectious Diagnostics Market, Mexico, Company Share (%) 2014
  • Figure 16: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 17: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 18: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 19: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 20: Infectious Diagnostics Market, United States, Company Share (%) 2014
Back to Top